| Safety and Efficacy of Mupirocin in Eradicating Colonization With S. Aureus in Critically Ill Infants (NCT01827358) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-04-30 |
| A Study of Combination Treatment With HF10 and Ipilimumab in Patients With Unresectable or Metastatic Melanoma (NCT02272855) | Takara Bio Inc. | 2014-04-30 |
| A Phase II Trial to Evaluate the Efficacy of AZD6094 (HMPL-504) in Patients With Papillary Renal Cell Carcinoma (PRCC) (NCT02127710) | AstraZeneca | 2014-04-30 |
| Long-term Safety and Efficacy of Momelotinib in Subjects With Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Polycythemia Vera or Essential Thrombocythemia (NCT02124746) | Sierra Oncology LLC - a GSK company | 2014-04-30 |
| Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease (NCT02013791) | Allergan | 2014-04-29 |
| A Trial to Assess the Safety and Effectiveness of Lutetium-177 Octreotate Therapy in Neuroendocrine Tumours (NCT01876771) | AHS Cancer Control Alberta | 2014-04-29 |
| Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection (NCT02038881) | Bavarian Nordic | 2014-04-28 |
| Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria (NCT02180412) | The University of Texas Medical Branch, Galveston | 2014-04-28 |
| A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects (NCT02120352) | ViiV Healthcare | 2014-04-28 |
| Phase 1/2 Study of Vorinostat Therapy in Niemann-Pick Disease, Type C1 (NCT02124083) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2014-04-25 |
| Is Intralymphatic Allergen Immunotherapy Effective and Safe? (NCT04210193) | Lars Olaf Cardell | 2014-04-25 |
| Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension. (NCT02017444) | University of Birmingham | 2014-04-25 |
| MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer (NCT02068794) | Mayo Clinic | 2014-04-25 |
| Ph 2B/3 Tafenoquine (TFQ) Study in Prevention of Vivax Relapse (NCT01376167) | GlaxoSmithKline | 2014-04-24 |
| Bone Antiresorptive Therapy With Antiretroviral Initiation (BATARI) Pilot Trial (NCT01968850) | Unity Health Toronto | 2014-04-23 |
| SAFIR02_Lung - Efficacy of Targeted Drugs Guided by Genomic Profiles in Metastatic NSCLC Patients (NCT02117167) | UNICANCER | 2014-04-23 |
| Ketamine Alcohol (in Treatment-Resistant Depression) (NCT02122562) | Mark Niciu | 2014-04-23 |
| Hyperpolarized Xenon Gas MR Imaging in NSCLC Radiotherapy (NCT02151604) | Oxford University Hospitals NHS Trust | 2014-04-23 |
| Effects of an Immunosuppressant Mycophenolate Mofetil or MMF on the Urinary Sodium Excretion Response to Mental Stress (NCT02432339) | Augusta University | 2014-04-22 |
| OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females (NCT02116361) | Allergan | 2014-04-22 |
| Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia (NCT01904136) | M.D. Anderson Cancer Center | 2014-04-22 |
| Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancer (NCT01804465) | University of California, San Francisco | 2014-04-22 |
| Computerized Cognition Testing in Participants With Mild Alzheimer's Disease (AD) Treated With Donepezil (MK-0000-318) (NCT02064920) | Merck Sharp & Dohme LLC | 2014-04-22 |
| Magnesium Sulphate for Severe Hand, Foot and Mouth Disease in Vietnam (NCT01940250) | Oxford University Clinical Research Unit, Vietnam | 2014-04-21 |
| Individualized Treatment Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA (NCT02135042) | NRG Oncology | 2014-04-21 |
| Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure (NCT02105766) | National Heart, Lung, and Blood Institute (NHLBI) | 2014-04-21 |
| Bevacizumab, Etoposide and Cisplatin Followed by Whole Brain Radiotherapy in Breast Cancer With Brain Metastases (NCT02185352) | National Taiwan University Hospital | 2014-04-21 |
| Study of SPARC1103 in Subjects With Spasticity (NCT02027025) | Sun Pharma Advanced Research Company Limited | 2014-04-21 |
| Study of Ruxolitinib in the Treatment of Cachexia in Patients With Tumor-Associated Chronic Wasting Diseases. (NCT02072057) | Kantonsspital Aarau | 2014-04-20 |
| Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study (NCT02081638) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-04-18 |
| ACTH in Progressive Forms of MS (NCT01950234) | University of Minnesota | 2014-04-17 |
| Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy (NCT02167217) | Washington University School of Medicine | 2014-04-17 |
| Treatment Substitution With PRO 140 Monotherapy in Adult Subjects With HIV-1 Infection (NCT02175680) | CytoDyn, Inc. | 2014-04-16 |
| A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial (NCT02057380) | Astellas Pharma Global Development, Inc. | 2014-04-16 |
| Cholecalciferol Supplementation in Strengthening Inspiratory Muscles in Cholecalciferol-Deficient Patients With Chronic Obstructive Pulmonary Disease (NCT02877641) | Roswell Park Cancer Institute | 2014-04-16 |
| A Study to Evaluate BMS-986036 in Obese Adults With Type-2 Diabetes (NCT02097277) | Bristol-Myers Squibb | 2014-04-15 |
| A Phase 1/2 Study Evaluating AMG 337 in Asian Subjects (NCT02096666) | Amgen | 2014-04-15 |
| Study to Evaluate the Efficacy and Safety of GX-E2 in the Anemic Patients Diagnosed With Chronic Kidney Disease (CKD) (NCT02044653) | Genexine, Inc. | 2014-04-15 |
| Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients (NCT02114658) | Bayer | 2014-04-15 |
| A Study to Evaluate the Safety and Efficacy of Topically Applied TV-45070 (Ointment) in Participants With Primary Osteoarthritis (OA) Affecting a Single Knee (NCT02068599) | Teva Branded Pharmaceutical Products R&D, Inc. | 2014-04-14 |
| Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy (NCT02062632) | Mayo Clinic | 2014-04-14 |
| My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors (NCT02091141) | Genentech, Inc. | 2014-04-14 |
| A Phase 2 Study to Evaluate the Efficacy and Safety of AMG531 in Aplastic Anemia (NCT02094417) | Kyowa Kirin Korea Co., Ltd. | 2014-04-14 |
| A Multicenter Open Label Phase II Study of Pomalidomide and Cyclophosphamide and Dexamethasone in Relapse/Refractory Multiple Myeloma Patients Who Were First Treated Within the IFM/DFCI 2009 Trial (PCD) (NCT02244125) | Institut Curie | 2014-04-14 |
| Triple in Asthma Dose Finding (NCT02127866) | Chiesi Farmaceutici S.p.A. | 2014-04-11 |
| Pegylated Interferon Alfa-2b and Nilotinib for Augmentation of Complete Molecular Response in Chronic Myeloid Leukaemia (NCT02001818) | Australasian Leukaemia and Lymphoma Group | 2014-04-11 |
| Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer (NCT02101788) | National Cancer Institute (NCI) | 2014-04-11 |
| Phase 2 Pilot Safety Study of MDMA-assisted Therapy for Social Anxiety in Autistic Adults (NCT02008396) | Resilient Pharmaceuticals | 2014-04-11 |
| Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children (NCT01858740) | Fred Hutchinson Cancer Center | 2014-04-10 |
| The Oslo Study of Clonidine in Elderly Patients With Delirium (NCT01956604) | Oslo University Hospital | 2014-04-10 |
| SCD-Haplo: Phase II Study of HLA-Haploidentical SCT for Aggressive SCD (NCT02013375) | Damiano Rondelli, MD | 2014-04-10 |
| Efficacy and Safety Study of TLC388 to Advanced Hepatocellular Carcinoma (NCT02267213) | Taiwan Liposome Company | 2014-04-10 |
| Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim2) (NCT02127125) | The University of Texas Health Science Center at San Antonio | 2014-04-10 |
| Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer (NCT02112552) | Albert Einstein College of Medicine | 2014-04-10 |
| Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery (NCT02031536) | ECOG-ACRIN Cancer Research Group | 2014-04-10 |
| Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer (NCT02009332) | Aadi Bioscience, Inc. | 2014-04-09 |
| Study of KPT-330 (Selinexor) in Female Patients With Advanced Gynaecologic Malignancies (NCT02025985) | Karyopharm Therapeutics Inc | 2014-04-09 |
| Dexmedetomidine and Outcomes of Cardiac Surgery (DOCS) (NCT02237495) | Xijing Hospital | 2014-04-09 |
| A Study Evaluating the Efficacy of Obinutuzumab and Bendamustine Treatment in Participants With Refractory or Relapsed Chronic Lymphocytic Leukemia (NCT02071225) | Hoffmann-La Roche | 2014-04-09 |
| A Vaccine (CDX-1401) With or Without a Biologic Drug (CDX-301) for the Treatment of Patients With Stage IIB-IV Melanoma (NCT02129075) | National Cancer Institute (NCI) | 2014-04-09 |
| Dabrafenib/Trametinib, BRAF or BRAF AND MEK Pre-op With BRAF and MEK Post-op, Phase IIB, Melanoma With Brain Mets,Biomarkers and Metabolites (NCT01978236) | GlaxoSmithKline | 2014-04-08 |
| Safety and Efficacy Study of SJP-0035 Ophthalmic Solution in Patients With Moderate to Severe Corneal Epithelial Disorders (NCT02104388) | Senju Pharmaceutical Co., Ltd. | 2014-04-08 |
| Pharmacokinetics of Intraperitoneal and Intravenous Meropenem, Ampicillin, Aztreonam and Ciprofloxacin in Automated Peritoneal Dialysis Patients Without Peritonitis (NCT07113587) | Karl Landsteiner Insitute for Nephrology and Haemato-Oncology | 2014-04-08 |
| Metformin and Muscle in Insulin-resistant Older Veterans (NCT01804049) | VA Office of Research and Development | 2014-04-08 |
| Third-line Treatment of Gefitinib in NSCLC Patients (NCT01933347) | Guangdong Association of Clinical Trials | 2014-04-07 |
| SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer (NCT02299999) | UNICANCER | 2014-04-07 |
| Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec (NCT02014441) | Amgen | 2014-04-07 |
| Control of Major Bleeding After Trauma Study (NCT01838863) | Denver Health and Hospital Authority | 2014-04-07 |
| A Phase 1/2 Study of Repeated Intravenous E6011 Administration in Japanese Subjects With Crohn's Disease (NCT02039063) | EA Pharma Co., Ltd. | 2014-04-05 |
| Nutritional Adequacy Therapeutic Enhancement in the Critically Ill. The NUTRIATE Study (NCT01934192) | GlaxoSmithKline | 2014-04-04 |
| Guadecitabine With or Without Idarubicin or Cladribine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia (NCT02096055) | M.D. Anderson Cancer Center | 2014-04-04 |
| GEM STUDY: Radiation And Yervoy in Patients With Melanoma and Brain Metastases (NCT02115139) | Grupo Español Multidisciplinar de Melanoma | 2014-04-04 |
| Comparing Anugel With Gelatine Sponges for Pain Management After Hemoroidectomy (NCT04057079) | Deep Life Medical Ltd | 2014-04-04 |
| Patients With Refractory, Metastatic Cancer Harboring KIT Mutation or Amplification to Investigate the Clinical Efficacy and Safety of Imatinib Therapy (NCT02461849) | Samsung Medical Center | 2014-04-04 |
| Zaleplon in HIV Patients With Depression (NCT03489304) | University of Pennsylvania | 2014-04-03 |
| Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer (NCT02101385) | Bryan Schneider, MD | 2014-04-03 |
| Open-Label Phase IIb Efficacy Trial of Cancer Macrobeads Compared to Best Supportive Care in Colorectal Cancer Patients (NCT02046174) | The Rogosin Institute | 2014-04-03 |
| Vemurafenib Plus Cobimetinib Plus PEG-interferon in Advanced Melanoma Patients Harboring the V600BRAF Mutation (NCT01959633) | Fondazione Melanoma Onlus | 2014-04-03 |
| Targeted Silica Nanoparticles for Real-Time Image-Guided Intraoperative Mapping of Nodal Metastases (NCT02106598) | Memorial Sloan Kettering Cancer Center | 2014-04-03 |
| A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma (NCT02029430) | ImmunityBio, Inc. | 2014-04-03 |
| ACY-1215 for Relapsed/Refractory Lymphoid Malignancies (NCT02091063) | Jennifer Amengual | 2014-04-02 |
| Dacomitinib Plus PD-0325901 in Advanced KRAS Mutant NSCLC (NCT02039336) | The Netherlands Cancer Institute | 2014-04-02 |
| Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim 1) (NCT02124759) | The University of Texas Health Science Center at San Antonio | 2014-04-02 |
| Evaluation of Dentin Hypersensitivity Using Glass Ionomer Cements (NCT02378129) | Federal University of Pelotas | 2014-04-02 |
| Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya (NCT01810731) | Centers for Disease Control and Prevention | 2014-04-01 |
| A Study to Evaluate Foretinib in Subjects With Non-Small-Cell Lung Cancer (NCT02034097) | GlaxoSmithKline | 2014-04-01 |
| Ruxolitinib in the Treatment of Chronic Lymphocytic Leukemia (NCT02015208) | Sunnybrook Health Sciences Centre | 2014-04-01 |
| Effect of Microvesicles and Exosomes Therapy on β-cell Mass in Type I Diabetes Mellitus (T1DM) (NCT02138331) | General Committee of Teaching Hospitals and Institutes, Egypt | 2014-04-01 |
| Resolving Bile Reflux by Lanreotide in Patients With Roux-en-Y Gastrojejunostomy (NCT02054637) | Universitair Ziekenhuis Brussel | 2014-04-01 |
| PK and PD of Single, Escalating Doses of PER977 Following Enoxaparin (NCT02206100) | Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. | 2014-04-01 |
| Eplerenone For the Treatment of Chronic Central Serous Chorioretinopathy (NCT02153125) | Tel-Aviv Sourasky Medical Center | 2014-04-01 |
| Image Guided Treatment Optimization With Cetuximab for Patients With Metastatic Colorectal Cancer (NCT02117466) | Amsterdam UMC, location VUmc | 2014-04-01 |
| Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas (NCT02129647) | NYU Langone Health | 2014-04-01 |
| A Trial of Imatinib for Patients With Aggressive Desmoid Tumor (Aggressive Fibromatosis) (NCT02495519) | Yonsei University | 2014-04-01 |
| A Randomized Phase II Clinical Trial on the Efficacy of Axitinib as a Monotherapy or in Combination With Lomustine for the Treatment of Patients With Recurrent Glioblastoma (NCT01562197) | Bart Neyns | 2014-04-01 |
| The Role of Adding Concurrent Chemotherapy to IMRT in the Treatment of Stage II Nasopharyngeal Carcinoma (NCT02116231) | Cancer Hospital of Guangxi Medical University | 2014-04-01 |
| Vitamin C Infusion for Treatment in Sepsis Induced Acute Lung Injury (NCT02106975) | Virginia Commonwealth University | 2014-04-01 |
| A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus (NCT02111096) | Eli Lilly and Company | 2014-04-01 |
| Efficacy of Methyl Aminolevulinate + Daylight in Patients With Facial Photodamage (NCT02139618) | Fundación Dermabase | 2014-04-01 |
| Pumpkin Seed Oil Supplementation in Premenopausal Women (NCT02119429) | Texas Woman's University | 2014-04-01 |